Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
19
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Atkins Susan E. | Director | 2 | $0 | $0 | 2026-08-12 |
| Rodriguez Javier | See Remarks | 70 | $0 | $81.6K | 2026-06-15 |
| Mehta Vimal | CEO, President, Secretary | 132 | $89.3K | $18.86M | 2026-06-15 |
| Yocca Frank | Chief Scientific Officer | 94 | $66.3K | $3.85M | 2026-06-15 |
| Steinhart Richard I | Senior VP and CFO | 84 | $7.6K | $372.2K | 2026-06-15 |
| Bray June | Director | 6 | $0 | $0 | 2026-01-09 |
| Laumas Sandeep | Director | 8 | $0 | $0 | 2026-01-09 |
| MACK DAVID J. | Director | 28 | $0 | $0 | 2026-01-09 |
| Votruba Michal | Director | 14 | $0 | $0 | 2026-01-09 |
| Patni Rajiv | Director | 2 | $0 | $0 | 2026-01-09 |
| MUELLER PETER | Director | 23 | $152.9K | $0 | 2026-01-09 |
| MILLER MICHAEL PATRICK | Director | 4 | $0 | $0 | 2026-01-09 |
| O'Neill Vincent | See Remarks | 57 | $0 | $4.82M | 2024-12-16 |
| Wiley Matthew T. | Other | 16 | $0 | $6.6K | 2024-10-03 |
| Nandabalan Krishnan | Director, 10% Owner | 25 | $4.9K | $17.85M | 2023-04-06 |
| Kane William P Jr | Chief Commercial Officer | 2 | $0 | $0 | 2021-08-16 |
| BioXcel Holdings, Inc. | 10% Owner | 4 | $0 | $14.59M | 2021-06-25 |
| BioXcel LLC | 10% Owner | 2 | $0 | $14.59M | 2021-06-25 |
| Benabou Reina | See Remarks | 1 | $0 | $0 | 2020-06-22 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Atkins Susan E. | Director | A Award deriv | 2026-08-12 | 2026-08-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Atkins Susan E. | Director | A Award deriv | 2026-08-12 | 2026-08-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2026-06-15 | 2026-06-17 | 219 | — | $0 | 1,313 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2026-06-15 | 2026-06-17 | 35 | — | $0 | 212 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2026-06-15 | 2026-06-17 | 35 | — | $0 | 212 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2026-06-15 | 2026-06-17 | 35 | — | $0 | 212 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2026-06-15 | 2026-06-17 | 219 | — | $0 | 69,817 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2026-06-15 | 2026-06-17 | 35 | — | $0 | 26,210 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2026-06-15 | 2026-06-17 | 35 | — | $0 | 26,335 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2026-06-15 | 2026-06-17 | 35 | — | $0 | 26,838 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2026-05-20 | 2026-05-22 | 19,419 | $1.09 | $21.2K | 69,598 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | S Sale | 2026-05-20 | 2026-05-22 | 6,845 | $1.09 | $7.5K | 26,300 | SEC↗ |
| Rodriguez Javier | See Remarks | S Sale | 2026-05-20 | 2026-05-22 | 6,560 | $1.08 | $7.1K | 26,803 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | S Sale | 2026-05-20 | 2026-05-22 | 6,845 | $1.09 | $7.5K | 26,175 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2026-05-04 | 2026-05-22 | 49,758 | — | $0 | 149,274 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2026-05-04 | 2026-05-22 | 17,500 | — | $0 | 52,500 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2026-05-04 | 2026-05-22 | 17,500 | — | $0 | 52,500 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2026-05-04 | 2026-05-22 | 17,500 | — | $0 | 52,500 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2026-05-04 | 2026-05-22 | 49,758 | — | $0 | 89,017 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2026-05-04 | 2026-05-22 | 17,500 | — | $0 | 33,145 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2026-05-04 | 2026-05-22 | 17,500 | — | $0 | 33,363 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2026-05-04 | 2026-05-22 | 17,500 | — | $0 | 33,020 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2026-05-01 | 2026-05-07 | 9,000 | — | $0 | 0 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2026-05-01 | 2026-05-07 | 9,000 | — | $0 | 0 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2026-05-01 | 2026-05-07 | 9,000 | — | $0 | 0 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2026-05-01 | 2026-05-07 | 18,000 | — | $0 | 0 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2026-05-01 | 2026-05-07 | 9,000 | — | $0 | 15,863 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2026-05-01 | 2026-05-07 | 9,000 | — | $0 | 15,520 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2026-05-01 | 2026-05-07 | 9,000 | — | $0 | 15,645 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2026-05-01 | 2026-05-07 | 18,000 | — | $0 | 39,259 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2026-03-15 | 2026-03-16 | 35 | — | $0 | 247 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2026-03-15 | 2026-03-16 | 35 | — | $0 | 247 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2026-03-15 | 2026-03-16 | 35 | — | $0 | 247 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2026-03-15 | 2026-03-16 | 219 | — | $0 | 1,532 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2026-03-15 | 2026-03-16 | 35 | — | $0 | 6,520 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2026-03-15 | 2026-03-16 | 35 | — | $0 | 6,863 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2026-03-15 | 2026-03-16 | 35 | — | $0 | 6,645 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2026-03-15 | 2026-03-16 | 219 | — | $0 | 21,259 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2026-03-14 | 2026-03-16 | 33 | — | $0 | 97 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2026-03-14 | 2026-03-16 | 33 | — | $0 | 97 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2026-03-14 | 2026-03-16 | 33 | — | $0 | 97 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2026-03-14 | 2026-03-16 | 164 | — | $0 | 488 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2026-03-14 | 2026-03-16 | 33 | — | $0 | 6,485 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2026-03-14 | 2026-03-16 | 33 | — | $0 | 6,828 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2026-03-14 | 2026-03-16 | 33 | — | $0 | 6,610 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2026-03-14 | 2026-03-16 | 164 | — | $0 | 21,040 | SEC↗ |
| MACK DAVID J. | Director | A Award deriv | 2026-01-09 | 2026-01-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Bray June | Director | A Award deriv | 2026-01-09 | 2026-01-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| MILLER MICHAEL PATRICK | Director | A Award deriv | 2026-01-09 | 2026-01-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Votruba Michal | Director | A Award deriv | 2026-01-09 | 2026-01-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| MUELLER PETER | Director | A Award deriv | 2026-01-09 | 2026-01-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Patni Rajiv | Director | A Award deriv | 2026-01-09 | 2026-01-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Laumas Sandeep | Director | A Award deriv | 2026-01-09 | 2026-01-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Rodriguez Javier | See Remarks | A Award deriv | 2026-01-01 | 2026-01-05 | 70,000 | — | $0 | 70,282 | SEC↗ |
| Mehta Vimal | CEO and President | A Award deriv | 2026-01-01 | 2026-01-05 | 199,032 | — | $0 | 200,783 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | A Award deriv | 2026-01-01 | 2026-01-05 | 70,000 | — | $0 | 70,282 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | A Award deriv | 2026-01-01 | 2026-01-05 | 70,000 | — | $0 | 70,282 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2025-12-15 | 2025-12-15 | 35 | — | $0 | 282 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2025-12-15 | 2025-12-15 | 35 | — | $0 | 282 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2025-12-15 | 2025-12-15 | 35 | — | $0 | 282 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2025-12-15 | 2025-12-15 | 219 | — | $0 | 1,751 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2025-12-15 | 2025-12-15 | 35 | — | $0 | 6,452 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2025-12-15 | 2025-12-15 | 35 | — | $0 | 6,795 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2025-12-15 | 2025-12-15 | 35 | — | $0 | 6,577 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2025-12-15 | 2025-12-15 | 219 | — | $0 | 20,876 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2025-12-14 | 2025-12-15 | 33 | — | $0 | 130 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2025-12-14 | 2025-12-15 | 33 | — | $0 | 130 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2025-12-14 | 2025-12-15 | 33 | — | $0 | 130 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2025-12-14 | 2025-12-15 | 164 | — | $0 | 652 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2025-12-14 | 2025-12-15 | 33 | — | $0 | 6,417 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2025-12-14 | 2025-12-15 | 33 | — | $0 | 6,760 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2025-12-14 | 2025-12-15 | 33 | — | $0 | 6,542 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2025-12-14 | 2025-12-15 | 164 | — | $0 | 20,657 | SEC↗ |
| MACK DAVID J. | Director | M Exercise deriv | 2025-10-31 | 2025-11-03 | 1,694 | — | $0 | 0 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2025-10-31 | 2025-11-03 | 1,694 | — | $0 | 20,317 | SEC↗ |
| MACK DAVID J. | Director | M Exercise deriv | 2025-09-30 | 2025-10-01 | 1,694 | — | $0 | 1,694 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2025-09-30 | 2025-10-01 | 1,694 | — | $0 | 18,623 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2025-09-15 | 2025-09-16 | 35 | — | $0 | 317 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2025-09-15 | 2025-09-16 | 35 | — | $0 | 317 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2025-09-15 | 2025-09-16 | 35 | — | $0 | 317 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2025-09-15 | 2025-09-16 | 219 | — | $0 | 1,970 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2025-09-15 | 2025-09-16 | 35 | — | $0 | 6,384 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2025-09-15 | 2025-09-16 | 35 | — | $0 | 6,727 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2025-09-15 | 2025-09-16 | 35 | — | $0 | 6,509 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2025-09-15 | 2025-09-16 | 219 | — | $0 | 20,493 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2025-09-14 | 2025-09-16 | 33 | — | $0 | 163 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2025-09-14 | 2025-09-16 | 33 | — | $0 | 163 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2025-09-14 | 2025-09-16 | 33 | — | $0 | 163 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2025-09-14 | 2025-09-16 | 163 | — | $0 | 816 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2025-09-14 | 2025-09-16 | 33 | — | $0 | 6,349 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2025-09-14 | 2025-09-16 | 33 | — | $0 | 6,692 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2025-09-14 | 2025-09-16 | 33 | — | $0 | 6,474 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2025-09-14 | 2025-09-16 | 163 | — | $0 | 20,274 | SEC↗ |
| MACK DAVID J. | Director | M Exercise deriv | 2025-08-31 | 2025-09-02 | 1,693 | — | $0 | 3,387 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2025-08-31 | 2025-09-02 | 1,693 | — | $0 | 16,930 | SEC↗ |
| Mehta Vimal | CEO and President | A Award deriv | 2025-08-01 | 2025-08-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | A Award deriv | 2025-08-01 | 2025-08-05 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Rodriguez Javier | See Remarks | A Award deriv | 2025-08-01 | 2025-08-05 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | A Award deriv | 2025-08-01 | 2025-08-05 | 9,000 | — | $0 | 9,000 | SEC↗ |
| MACK DAVID J. | Director | M Exercise deriv | 2025-07-31 | 2025-07-31 | 1,693 | — | $0 | 5,080 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2025-07-31 | 2025-07-31 | 1,693 | — | $0 | 15,237 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2025-07-22 | 2025-07-22 | 625 | — | $0 | 0 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2025-07-22 | 2025-07-22 | 625 | — | $0 | 0 | SEC↗ |
| Rodriguez Javier | See Remarks | A Award | 2025-07-22 | 2025-07-22 | 4,375 | — | $0 | 6,034 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2025-07-22 | 2025-07-22 | 625 | — | $0 | 6,659 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2025-07-22 | 2025-07-22 | 625 | — | $0 | 6,441 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | A Award | 2025-07-22 | 2025-07-22 | 4,375 | — | $0 | 5,816 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | A Award | 2025-07-22 | 2025-07-22 | 4,375 | — | $0 | 6,316 | SEC↗ |
| Mehta Vimal | CEO and President | A Award | 2025-07-22 | 2025-07-22 | 15,625 | — | $0 | 20,111 | SEC↗ |
| MACK DAVID J. | Director | M Exercise deriv | 2025-06-30 | 2025-06-30 | 1,693 | — | $0 | 6,773 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2025-06-30 | 2025-06-30 | 1,693 | — | $0 | 13,544 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2025-06-15 | 2025-06-16 | 35 | — | $0 | 352 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2025-06-15 | 2025-06-16 | 219 | — | $0 | 2,189 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2025-06-15 | 2025-06-16 | 35 | — | $0 | 352 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2025-06-15 | 2025-06-16 | 35 | — | $0 | 352 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2025-06-15 | 2025-06-16 | 35 | — | $0 | 1,659 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2025-06-15 | 2025-06-16 | 219 | — | $0 | 4,486 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2025-06-15 | 2025-06-16 | 35 | — | $0 | 1,941 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2025-06-15 | 2025-06-16 | 35 | — | $0 | 1,441 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2025-06-14 | 2025-06-16 | 33 | — | $0 | 196 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2025-06-14 | 2025-06-16 | 163 | — | $0 | 979 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2025-06-14 | 2025-06-16 | 33 | — | $0 | 196 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2025-06-14 | 2025-06-16 | 33 | — | $0 | 196 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2025-06-14 | 2025-06-16 | 33 | — | $0 | 1,624 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2025-06-14 | 2025-06-16 | 163 | — | $0 | 4,267 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2025-06-14 | 2025-06-16 | 33 | — | $0 | 1,906 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2025-06-14 | 2025-06-16 | 33 | — | $0 | 1,406 | SEC↗ |
| MACK DAVID J. | Director | M Exercise deriv | 2025-05-31 | 2025-06-02 | 1,693 | — | $0 | 8,466 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2025-05-31 | 2025-06-02 | 1,693 | — | $0 | 11,851 | SEC↗ |
| MACK DAVID J. | Director | M Exercise deriv | 2025-04-30 | 2025-05-01 | 1,693 | — | $0 | 10,159 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2025-04-30 | 2025-05-01 | 1,693 | — | $0 | 10,158 | SEC↗ |
| MACK DAVID J. | Director | M Exercise deriv | 2025-03-31 | 2025-04-01 | 1,693 | — | $0 | 11,852 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2025-03-31 | 2025-04-01 | 1,693 | — | $0 | 8,465 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2025-03-15 | 2025-03-17 | 217 | — | $0 | 2,408 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2025-03-15 | 2025-03-17 | 34 | — | $0 | 387 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2025-03-15 | 2025-03-17 | 34 | — | $0 | 387 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2025-03-15 | 2025-03-17 | 34 | — | $0 | 387 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2025-03-15 | 2025-03-17 | 217 | — | $0 | 4,104 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2025-03-15 | 2025-03-17 | 34 | — | $0 | 1,873 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2025-03-15 | 2025-03-17 | 34 | — | $0 | 1,591 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2025-03-15 | 2025-03-17 | 34 | — | $0 | 1,373 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2025-03-14 | 2025-03-17 | 162 | — | $0 | 1,142 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2025-03-14 | 2025-03-17 | 31 | — | $0 | 229 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2025-03-14 | 2025-03-17 | 31 | — | $0 | 229 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2025-03-14 | 2025-03-17 | 31 | — | $0 | 229 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2025-03-14 | 2025-03-17 | 162 | — | $0 | 3,887 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2025-03-14 | 2025-03-17 | 31 | — | $0 | 1,839 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2025-03-14 | 2025-03-17 | 31 | — | $0 | 1,557 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2025-03-14 | 2025-03-17 | 31 | — | $0 | 1,339 | SEC↗ |
| MACK DAVID J. | Director | M Exercise deriv | 2025-02-28 | 2025-03-04 | 1,693 | — | $0 | 13,545 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2025-02-28 | 2025-03-04 | 1,693 | — | $0 | 6,772 | SEC↗ |
| MACK DAVID J. | Director | M Exercise deriv | 2025-01-31 | 2025-02-04 | 27,089 | — | $0 | 243,810 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2025-01-31 | 2025-02-04 | 27,089 | — | $0 | 81,267 | SEC↗ |
| Patni Rajiv | Director | A Award deriv | 2025-01-15 | 2025-01-16 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | A Award deriv | 2025-01-07 | 2025-01-10 | 270,000 | — | $0 | 270,000 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | A Award deriv | 2025-01-07 | 2025-01-10 | 270,000 | — | $0 | 270,000 | SEC↗ |
| Mehta Vimal | CEO and President | A Award deriv | 2025-01-07 | 2025-01-10 | 660,000 | — | $0 | 660,000 | SEC↗ |
| MACK DAVID J. | Director | M Exercise deriv | 2024-12-31 | 2025-01-03 | 27,089 | — | $0 | 270,899 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2024-12-31 | 2025-01-03 | 27,089 | — | $0 | 54,178 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | S Sale | 2024-12-16 | 2024-12-17 | 225 | $0.35 | $79 | 28,931 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | S Sale | 2024-12-16 | 2024-12-17 | 205 | $0.36 | $74 | 29,156 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | S Sale | 2024-12-16 | 2024-12-17 | 372 | $0.36 | $134 | 20,932 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | S Sale | 2024-12-16 | 2024-12-17 | 205 | $0.36 | $74 | 21,157 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2024-12-16 | 2024-12-17 | 2,134 | $0.36 | $768 | 59,605 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2024-12-16 | 2024-12-17 | 983 | $0.36 | $354 | 60,920 | SEC↗ |
| O'Neill Vincent | See Remarks | S Sale | 2024-12-16 | 2024-12-17 | 165 | $0.35 | $58 | 19,957 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2024-12-15 | 2024-12-17 | 562 | — | $0 | 5,064 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2024-12-15 | 2024-12-17 | 562 | — | $0 | 5,064 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2024-12-15 | 2024-12-17 | 3,500 | — | $0 | 31,500 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2024-12-15 | 2024-12-17 | 562 | — | $0 | 29,361 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2024-12-15 | 2024-12-17 | 562 | — | $0 | 21,362 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2024-12-15 | 2024-12-17 | 3,500 | — | $0 | 61,903 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2024-12-14 | 2024-12-17 | 521 | — | $0 | 2,606 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2024-12-14 | 2024-12-17 | 521 | — | $0 | 2,606 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2024-12-14 | 2024-12-17 | 2,610 | — | $0 | 13,049 | SEC↗ |
| O'Neill Vincent | See Remarks | M Exercise deriv | 2024-12-14 | 2024-12-17 | 521 | — | $0 | 2,606 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2024-12-14 | 2024-12-17 | 521 | — | $0 | 28,799 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2024-12-14 | 2024-12-17 | 521 | — | $0 | 20,800 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2024-12-14 | 2024-12-17 | 2,610 | — | $0 | 58,403 | SEC↗ |
| O'Neill Vincent | See Remarks | M Exercise | 2024-12-14 | 2024-12-17 | 521 | — | $0 | 20,122 | SEC↗ |
| MACK DAVID J. | Director | M Exercise deriv | 2024-11-30 | 2024-12-04 | 27,089 | — | $0 | 297,988 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2024-11-30 | 2024-12-03 | 27,089 | — | $0 | 27,089 | SEC↗ |
| MACK DAVID J. | Director | M Exercise | 2024-11-30 | 2024-12-04 | 27,089 | — | $0 | 27,089 | SEC↗ |
| MACK DAVID J. | Director | A Award deriv | 2024-11-21 | 2024-11-25 | 325,077 | — | $0 | 325,077 | SEC↗ |
| MACK DAVID J. | Director | A Award deriv | 2024-11-21 | 2024-12-03 | 297,988 | — | $0 | 297,998 | SEC↗ |
| O'Neill Vincent | See Remarks | S Sale | 2024-10-03 | 2024-10-03 | 5,556 | $0.55 | $3.1K | 19,601 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | S Sale | 2024-10-03 | 2024-10-03 | 7,175 | $0.55 | $3.9K | 20,279 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | S Sale | 2024-10-03 | 2024-10-03 | 7,175 | $0.55 | $3.9K | 28,278 | SEC↗ |
| Rodriguez Javier | See Remarks | S Sale | 2024-10-03 | 2024-10-03 | 6,863 | $0.55 | $3.8K | 23,770 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | S Sale | 2024-10-03 | 2024-10-03 | 6,272 | $0.55 | $3.4K | 19,011 | SEC↗ |
| O'Neill Vincent | See Remarks | A Award | 2024-09-17 | 2024-10-03 | 21,250 | — | $0 | 25,157 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | A Award | 2024-09-17 | 2024-10-03 | 21,250 | — | $0 | 27,454 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | A Award | 2024-09-17 | 2024-10-03 | 21,250 | — | $0 | 35,453 | SEC↗ |
| Rodriguez Javier | See Remarks | A Award | 2024-09-17 | 2024-10-03 | 21,250 | — | $0 | 30,633 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | A Award | 2024-09-17 | 2024-10-03 | 21,250 | — | $0 | 25,283 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | S Sale | 2024-09-16 | 2024-09-17 | 215 | $0.69 | $148 | 4,033 | SEC↗ |
| O'Neill Vincent | See Remarks | S Sale | 2024-09-16 | 2024-09-17 | 138 | $0.69 | $95 | 3,907 | SEC↗ |
| Rodriguez Javier | See Remarks | S Sale | 2024-09-16 | 2024-09-17 | 345 | $0.69 | $238 | 9,133 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | S Sale | 2024-09-16 | 2024-09-17 | 356 | $0.69 | $246 | 6,204 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2024-09-16 | 2024-09-17 | 1,150 | $0.69 | $793 | 51,666 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2024-09-16 | 2024-09-17 | 832 | $0.69 | $574 | 52,816 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | S Sale | 2024-09-16 | 2024-09-17 | 355 | $0.69 | $245 | 14,203 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | M Exercise deriv | 2024-09-15 | 2024-09-17 | 750 | — | $0 | 7,500 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2024-09-15 | 2024-09-17 | 563 | — | $0 | 5,625 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2024-09-15 | 2024-09-17 | 563 | — | $0 | 5,625 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2024-09-15 | 2024-09-17 | 3,500 | — | $0 | 35,000 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2024-09-15 | 2024-09-17 | 563 | — | $0 | 5,625 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | M Exercise | 2024-09-15 | 2024-09-17 | 750 | — | $0 | 4,248 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2024-09-15 | 2024-09-17 | 563 | — | $0 | 9,478 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2024-09-15 | 2024-09-17 | 563 | — | $0 | 6,560 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2024-09-15 | 2024-09-17 | 3,500 | — | $0 | 53,648 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2024-09-15 | 2024-09-17 | 563 | — | $0 | 14,558 | SEC↗ |
| O'Neill Vincent | See Remarks | M Exercise deriv | 2024-09-14 | 2024-09-17 | 521 | — | $0 | 3,127 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2024-09-14 | 2024-09-17 | 521 | — | $0 | 3,127 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2024-09-14 | 2024-09-17 | 521 | — | $0 | 3,127 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2024-09-14 | 2024-09-17 | 2,609 | — | $0 | 15,657 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2024-09-14 | 2024-09-17 | 521 | — | $0 | 3,127 | SEC↗ |
| O'Neill Vincent | See Remarks | M Exercise | 2024-09-14 | 2024-09-17 | 521 | — | $0 | 4,045 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2024-09-14 | 2024-09-17 | 521 | — | $0 | 8,915 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2024-09-14 | 2024-09-17 | 521 | — | $0 | 5,997 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2024-09-14 | 2024-09-17 | 2,609 | — | $0 | 50,148 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2024-09-14 | 2024-09-17 | 521 | — | $0 | 13,995 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | A Award deriv | 2024-07-22 | 2025-04-01 | 1,875 | — | $0 | 1,875 | SEC↗ |
| Rodriguez Javier | See Remarks | A Award deriv | 2024-07-22 | 2025-04-01 | 625 | — | $0 | 625 | SEC↗ |
| Rodriguez Javier | See Remarks | A Award deriv | 2024-07-22 | 2025-04-01 | 1,875 | — | $0 | 1,875 | SEC↗ |
| Wiley Matthew T. | Other | A Award deriv | 2024-07-22 | 2025-04-01 | 1,875 | — | $0 | 1,875 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | A Award deriv | 2024-07-22 | 2025-04-01 | 625 | — | $0 | 625 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | A Award deriv | 2024-07-22 | 2025-04-01 | 1,875 | — | $0 | 1,875 | SEC↗ |
| Mehta Vimal | CEO and President | A Award deriv | 2024-07-22 | 2025-04-01 | 6,250 | — | $0 | 6,250 | SEC↗ |
| O'Neill Vincent | Other | A Award deriv | 2024-07-22 | 2025-04-01 | 1,875 | — | $0 | 1,875 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2024-06-17 | 2024-06-18 | 2,134 | $1.28 | $2.7K | 47,539 | SEC↗ |
| O'Neill Vincent | See Remarks | S Sale | 2024-06-17 | 2024-06-18 | 155 | $1.29 | $200 | 3,524 | SEC↗ |
| Rodriguez Javier | See Remarks | S Sale | 2024-06-17 | 2024-06-18 | 361 | $1.26 | $455 | 8,394 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | S Sale | 2024-06-17 | 2024-06-18 | 372 | $1.26 | $469 | 5,476 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | S Sale | 2024-06-17 | 2024-06-18 | 244 | $1.26 | $307 | 3,498 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | S Sale | 2024-06-17 | 2024-06-18 | 372 | $1.28 | $476 | 13,474 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | M Exercise deriv | 2024-06-15 | 2024-09-17 | 750 | — | $0 | 8,250 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2024-06-15 | 2024-06-18 | 3,500 | — | $0 | 38,500 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2024-06-15 | 2024-06-18 | 562 | — | $0 | 6,188 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2024-06-15 | 2024-06-18 | 562 | — | $0 | 6,188 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | M Exercise deriv | 2024-06-15 | 2024-06-18 | 750 | — | $0 | 8,250 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2024-06-15 | 2024-06-18 | 562 | — | $0 | 6,188 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2024-06-15 | 2024-06-18 | 3,500 | — | $0 | 49,673 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2024-06-15 | 2024-06-18 | 562 | — | $0 | 8,755 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2024-06-15 | 2024-06-18 | 562 | — | $0 | 5,848 | SEC↗ |
| Wiley Matthew T. | Chief Commercial Officer | M Exercise | 2024-06-15 | 2024-06-18 | 750 | — | $0 | 3,742 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2024-06-15 | 2024-06-18 | 562 | — | $0 | 13,846 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2024-06-14 | 2024-06-18 | 2,609 | — | $0 | 18,266 | SEC↗ |
| O'Neill Vincent | See Remarks | M Exercise deriv | 2024-06-14 | 2024-06-18 | 521 | — | $0 | 3,648 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2024-06-14 | 2024-06-18 | 521 | — | $0 | 3,648 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2024-06-14 | 2024-06-18 | 521 | — | $0 | 3,648 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2024-06-14 | 2024-06-18 | 521 | — | $0 | 3,648 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2024-06-14 | 2024-06-18 | 2,609 | — | $0 | 46,173 | SEC↗ |
| O'Neill Vincent | See Remarks | M Exercise | 2024-06-14 | 2024-06-18 | 521 | — | $0 | 3,679 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2024-06-14 | 2024-06-18 | 521 | — | $0 | 8,193 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2024-06-14 | 2024-06-18 | 521 | — | $0 | 5,286 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2024-06-14 | 2024-06-18 | 521 | — | $0 | 13,284 | SEC↗ |
| Bray June | Director | A Award deriv | 2024-06-10 | 2024-06-11 | 17,000 | — | $0 | 17,000 | SEC↗ |
| MILLER MICHAEL PATRICK | Director | A Award deriv | 2024-06-10 | 2024-06-11 | 17,000 | — | $0 | 17,000 | SEC↗ |
| MUELLER PETER | Director | A Award deriv | 2024-06-10 | 2024-06-11 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Laumas Sandeep | Director | A Award deriv | 2024-06-10 | 2024-06-11 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Votruba Michal | Director | J Other deriv | 2024-06-10 | 2024-06-11 | 17,000 | — | $0 | 0 | SEC↗ |
| Votruba Michal | Director | A Award deriv | 2024-06-10 | 2024-06-11 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2024-06-05 | 2024-06-06 | 283,122 | — | $0 | 0 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2024-06-05 | 2024-06-06 | 126,014 | $1.58 | $199.1K | 7,685,501 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale deriv | 2024-06-04 | 2024-06-06 | 120 | — | $0 | 120 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2024-06-04 | 2024-06-06 | 126,014 | $1.63 | $205.4K | 7,811,515 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2024-06-04 | 2024-06-06 | 609,221 | — | $0 | 7,937,529 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2024-06-04 | 2024-06-06 | 283,123 | — | $0 | 283,122 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | S Sale | 2024-04-04 | 2024-04-08 | 1,067 | $2.64 | $2.8K | 12,763 | SEC↗ |
| Rodriguez Javier | See Remarks | S Sale | 2024-04-04 | 2024-04-08 | 1,012 | $2.64 | $2.7K | 7,672 | SEC↗ |
| Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | S Sale | 2024-04-04 | 2024-04-08 | 1,008 | $2.64 | $2.7K | 2,992 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | S Sale | 2024-04-04 | 2024-04-08 | 1,069 | $2.64 | $2.8K | 4,765 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2024-04-04 | 2024-04-08 | 4,439 | $2.62 | $11.6K | 43,564 | SEC↗ |
| Mehta Vimal | CEO and President | S Sale | 2024-04-04 | 2024-04-08 | 829 | $2.62 | $2.2K | 48,003 | SEC↗ |
| O'Neill Vincent | See Remarks | S Sale | 2024-04-04 | 2024-04-08 | 165 | $2.62 | $432 | 5,408 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2024-03-15 | 2024-04-08 | 2,250 | — | $0 | 6,750 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2024-03-15 | 2024-04-08 | 2,250 | — | $0 | 6,750 | SEC↗ |
| Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | M Exercise deriv | 2024-03-15 | 2024-04-08 | 3,000 | — | $0 | 9,000 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2024-03-15 | 2024-04-08 | 2,250 | — | $0 | 6,750 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2024-03-15 | 2024-04-08 | 14,000 | — | $0 | 42,000 | SEC↗ |
| O'Neill Vincent | See Remarks | M Exercise deriv | 2024-03-15 | 2024-04-08 | 2,250 | — | $0 | 6,750 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2024-03-15 | 2024-04-08 | 2,250 | — | $0 | 13,830 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2024-03-15 | 2024-04-08 | 2,250 | — | $0 | 8,684 | SEC↗ |
| Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | M Exercise | 2024-03-15 | 2024-04-08 | 3,000 | — | $0 | 3,000 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2024-03-15 | 2024-04-08 | 2,250 | — | $0 | 5,834 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2024-03-15 | 2024-04-08 | 14,000 | — | $0 | 48,832 | SEC↗ |
| O'Neill Vincent | See Remarks | M Exercise | 2024-03-15 | 2024-04-08 | 2,250 | — | $0 | 5,573 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise deriv | 2024-03-14 | 2024-04-08 | 521 | — | $0 | 4,169 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise deriv | 2024-03-14 | 2024-04-08 | 521 | — | $0 | 4,169 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2024-03-14 | 2024-04-08 | 521 | — | $0 | 4,169 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise deriv | 2024-03-14 | 2024-04-08 | 2,610 | — | $0 | 20,875 | SEC↗ |
| O'Neill Vincent | See Remarks | M Exercise deriv | 2024-03-14 | 2024-04-08 | 521 | — | $0 | 4,169 | SEC↗ |
| Yocca Frank | Chief Scientific Officer | M Exercise | 2024-03-14 | 2024-04-08 | 521 | — | $0 | 11,580 | SEC↗ |
| Rodriguez Javier | See Remarks | M Exercise | 2024-03-14 | 2024-04-08 | 521 | — | $0 | 6,434 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise | 2024-03-14 | 2024-04-08 | 521 | — | $0 | 3,584 | SEC↗ |
| Mehta Vimal | CEO and President | M Exercise | 2024-03-14 | 2024-04-08 | 2,610 | — | $0 | 34,832 | SEC↗ |
| O'Neill Vincent | See Remarks | M Exercise | 2024-03-14 | 2024-04-08 | 521 | — | $0 | 3,323 | SEC↗ |
| O'Neill Vincent | Chief Medical Officer | M Exercise deriv | 2023-12-14 | 2023-12-18 | 521 | — | $0 | 4,690 | SEC↗ |
| Steinhart Richard I | Chief Financial Officer | M Exercise deriv | 2023-12-14 | 2023-12-18 | 521 | — | $0 | 4,690 | SEC↗ |